/Companies

Aignostics

Berlin, DE · 5 known investors

Find your way into Aignostics

Sign up to see every warm intro you have to Aignostics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aignostics team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams. A spin-off from Charité Berlin, it works with academic and industry partners on tissue analysis validated by pathologists, from early drug discovery through regulated clinical applications.

Founders & leadership

FK
Frederick KlauschenFounder
MA
Maximilian AlberFounder
VM
Viktor MatyasFounder

Investors · 5

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Aignostics do?
Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams. A spin-off from Charité Berlin, it works with academic and industry partners on tissue analysis validated by pathologists, from early drug discovery through regulated clinical applications.
Who are Aignostics's investors?
Aignostics's investors include CARMA FUND, Boehringer Ingelheim Venture Fund, HTGF, IBB Ventures, Mayo Clinic Ventures.
Where is Aignostics headquartered?
Aignostics is headquartered in Berlin, DE.